<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
        <title>JBJI - recent articles</title>


    <link rel="self" href="https://jbji.copernicus.org/articles/"/>
    <id>https://jbji.copernicus.org/articles/</id>
    <updated>2026-04-17T18:05:47+02:00</updated>
    <author>
        <name>Copernicus Publications</name>
    </author>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-229-2026</id>
            <title type="html">Empirical antibiotic therapy in acute orthopaedic infections: differences in antimicrobial susceptibility across anatomical sites
            </title>
            <link href="https://doi.org/10.5194/jbji-11-229-2026"/>
            <summary type="html">
                &lt;b&gt;Empirical antibiotic therapy in acute orthopaedic infections: differences in antimicrobial susceptibility across anatomical sites&lt;/b&gt;&lt;br&gt;
                Yoni Lodewijk-van den Brink, Jon H. M. Goosen, Denise S. C. Telgt, Marrigje Nabuurs-Franssen, and Karin C. M. Veerman&lt;br&gt;
                    J. Bone Joint Infect., 11, 229&#8211;235, https://doi.org/10.5194/jbji-11-229-2026, 2026&lt;br&gt;
                Early postoperative orthopaedic infections require rapid empirical antibiotic treatment, but the optimal regimen may differ by anatomical site. In this retrospective cohort study, empirical coverage was evaluated across anatomical sites. Vancomycin combined with ceftriaxone provided high coverage for most sites, while foot and ankle infections showed higher rates of resistant Gram-negative bacteria. These findings support an anatomy-specific approach to treatment.
            </summary>
            <content type="html">
                &lt;b&gt;Empirical antibiotic therapy in acute orthopaedic infections: differences in antimicrobial susceptibility across anatomical sites&lt;/b&gt;&lt;br&gt;
                Yoni Lodewijk-van den Brink, Jon H. M. Goosen, Denise S. C. Telgt, Marrigje Nabuurs-Franssen, and Karin C. M. Veerman&lt;br&gt;
                    J. Bone Joint Infect., 11, 229&#8211;235, https://doi.org/10.5194/jbji-11-229-2026, 2026&lt;br&gt;
                <p><strong>Background:</strong&gt; The selection of empirical antibiotic therapy for early postoperative orthopaedic infections is challenging because pathogen distribution, antimicrobial resistance, and microbiology vary locally and by anatomical site. Dutch national guidelines from the Dutch Working Party on Antibiotic Policy (SWAB) recommend vancomycin-based combination therapy for prosthetic joint infection (PJI), but the adequacy of these regimens for the broader spectrum of early postoperative orthopaedic infections has not been systematically evaluated. <strong>Methods:</strong&gt; We conducted a retrospective, single-centre cohort study including early postoperative orthopaedic infections (<span class="inline-formula">&amp;#8804;</span>&amp;#8201;90&amp;#8201;d) treated between January 2022 and January 2025 with complete microbiological- and antimicrobial-susceptibility data. Microbiological isolates, susceptibility profiles, anatomical location, and the type of index procedure were analysed. Empirical coverage was assessed for cefazolin, vancomycin&amp;#8211;ceftriaxone (SWAB-recommended), and vancomycin&amp;#8211;ciprofloxacin, both overall and stratified by anatomical site. <strong>Results:</strong&gt; A total of 304 infections were included. Gram-positive organisms predominated, including <i>Staphylococcus aureus</i&gt; (one MRSA isolate) and coagulase-negative staphylococci, alongside Gram-negative bacteria, mainly <i>Enterobacter</i&gt; spp. Despite high cefazolin susceptibility among <i>S. aureus</i>, cefazolin monotherapy covered only 49&amp;#8201;% of infections due to resistance in <i>S. epidermidis</i&gt; and Gram-negative pathogens. Vancomycin&amp;#8211;ceftriaxone provided 89.8&amp;#8201;% coverage and increased to approximately 93.4&amp;#8201;% when foot and ankle infections were excluded; this subgroup showed frequent ceftriaxone-resistant <i>Enterobacter</i&gt; spp. Vancomycin&amp;#8211;ciprofloxacin achieved the highest coverage (97.7&amp;#8201;%). <strong>Conclusion:</strong&gt; Cefazolin monotherapy is insufficient as an empirical treatment for early postoperative orthopaedic infections at our centre. Vancomycin&amp;#8211;ceftriaxone offers high coverage for most anatomical sites and aligns with SWAB recommendations. For foot and ankle infections, vancomycin&amp;#8211;ciprofloxacin offers superior coverage.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-04-15T18:05:47+02:00</published>
            <updated>2026-04-15T18:05:47+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-219-2026</id>
            <title type="html">Twenty common errors in the prevention, diagnosis,  and treatment of fracture-related infection (FRI)
            </title>
            <link href="https://doi.org/10.5194/jbji-11-219-2026"/>
            <summary type="html">
                &lt;b&gt;Twenty common errors in the prevention, diagnosis,  and treatment of fracture-related infection (FRI)&lt;/b&gt;&lt;br&gt;
                Goran Georgievski, Nike Walter, Ronald Man Yeung Wong, Irene Katharina Sigmund, Ashok Kanuri, Christian Heiss, and Markus Rupp&lt;br&gt;
                    J. Bone Joint Infect., 11, 219&#8211;228, https://doi.org/10.5194/jbji-11-219-2026, 2026&lt;br&gt;
                This article outlines 20 common errors in the prevention, diagnosis, and management of fracture-related infection (FRI), highlighting their clinical consequences and providing practical recommendations for avoiding them. By addressing typical pitfalls and emphasizing standardized procedures and interdisciplinary collaboration, the article aims to improve patient safety and treatment outcomes.
            </summary>
            <content type="html">
                &lt;b&gt;Twenty common errors in the prevention, diagnosis,  and treatment of fracture-related infection (FRI)&lt;/b&gt;&lt;br&gt;
                Goran Georgievski, Nike Walter, Ronald Man Yeung Wong, Irene Katharina Sigmund, Ashok Kanuri, Christian Heiss, and Markus Rupp&lt;br&gt;
                    J. Bone Joint Infect., 11, 219&#8211;228, https://doi.org/10.5194/jbji-11-219-2026, 2026&lt;br&gt;
                <p>Fracture-related infections are among the most serious complications following osteosynthesis. They jeopardize fracture healing, prolong treatment duration, and can lead to loss of function or even amputation. Despite established standards, avoidable errors continue to occur in clinical practice. Fracture-related infections not only compromise healing but also significantly reduce life expectancy, and increase morbidity and mortality. The standardization of procedures is essential to improve outcomes and ensure consistent high-quality care. This article describes 20 common errors in the prevention, diagnosis, and treatment of fracture-related infection. For each error, the clinical consequences and practical recommendations are provided. The aim is to improve treatment quality and patient safety by identifying and avoiding typical decision-making pitfalls. Consistent standardization of surgical and microbiological procedures, interdisciplinary collaboration, and structured follow-up care are essential prerequisites for successful infection management.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-04-13T18:05:47+02:00</published>
            <updated>2026-04-13T18:05:47+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-207-2026</id>
            <title type="html">Is there a role for lavage aspiration after a dry tap in the work-up for potential periprosthetic joint infection?  A systematic review
            </title>
            <link href="https://doi.org/10.5194/jbji-11-207-2026"/>
            <summary type="html">
                &lt;b&gt;Is there a role for lavage aspiration after a dry tap in the work-up for potential periprosthetic joint infection?  A systematic review&lt;/b&gt;&lt;br&gt;
                Sander Bruyninckx, Stijn Ghijselings, Melissa Depypere, Alex Soriano, Willem-Jan Metsemakers, and Georges Vles&lt;br&gt;
                    J. Bone Joint Infect., 11, 207&#8211;217, https://doi.org/10.5194/jbji-11-207-2026, 2026&lt;br&gt;
                <div class="flex max-w-full flex-col">
<div class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&]:mt-1" dir="auto" data-message-author-role="assistant" data-message-id="571c3a74-2a2f-48cf-a384-a8749815f6ad" data-message-model-slug="gpt-5-2">
<div class="flex w-full flex-col gap-1 empty:hidden first:pt-[1px]">
<div class="markdown prose dark:prose-invert w-full break-words dark markdown-new-styling">
<p data-start="0" data-end="568" data-is-last-node="" data-is-only-node="">When infection around an artificial hip or knee is suspected, joint fluid sampling is essential but often unsuccessful. We performed a systematic review to evaluate whether rinsing the joint with sterile salt water after an unsuccessful attempt improves diagnosis. Our findings show that this approach is safe, yields testable fluid in nearly all cases, and identifies infection in about one in five patients that would otherwise be missed.</p>
</div>
</div>
</div>
</div>
            </summary>
            <content type="html">
                &lt;b&gt;Is there a role for lavage aspiration after a dry tap in the work-up for potential periprosthetic joint infection?  A systematic review&lt;/b&gt;&lt;br&gt;
                Sander Bruyninckx, Stijn Ghijselings, Melissa Depypere, Alex Soriano, Willem-Jan Metsemakers, and Georges Vles&lt;br&gt;
                    J. Bone Joint Infect., 11, 207&#8211;217, https://doi.org/10.5194/jbji-11-207-2026, 2026&lt;br&gt;
                <p><strong>Aim</strong>: Lavage aspiration following a dry tap remains a debated technique in the work-up for periprosthetic joint infection (PJI) of the hip and knee. This systematic review critically appraises the available evidence, with a particular focus on the diagnostic yield of lavage aspiration in detecting PJIs that would otherwise be missed. <strong>Methods</strong>: A comprehensive literature search was conducted in accordance with PRISMA guidelines across PubMed, Embase, MEDLINE, and Cochrane databases. <strong>Results</strong>: Eleven studies met the inclusion criteria, all level IV case series. Across 1965 patients, 2199 aspirations were performed. Overall, 798 procedures (36&amp;#8201;%) resulted in a dry tap. Lavage aspiration was attempted in 698 of these cases, with 691 successful attempts. Among dry taps, 154 PJIs were ultimately identified, corresponding to a PJI prevalence of 19&amp;#8201;%. Lavage aspiration contributed to a correct diagnosis in 22&amp;#8201;% of successful procedures. Pooled culture sensitivity and specificity following saline lavage were 66&amp;#8201;% and 89&amp;#8201;%, respectively. The diagnostic performance of polymorphonuclear neutrophils (PMNs) <span class="inline-formula">>80</span>&amp;#8201;% was similar between saline lavage and normal aspiration. Although no safety concerns were reported, the potential introduction of pathogens and the risk of false-positive results remain concerns that are not fully mitigated by the available evidence. <strong>Conclusion</strong>: One in three aspirations result in a dry tap. Lavage aspiration provides analysable fluid in nearly all cases and appears to enable the diagnosis of PJI in roughly one out of five patients in whom standard aspiration fails. However, more robust evidence is needed before it can be recommended as a universal technique.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-04-09T18:05:47+02:00</published>
            <updated>2026-04-09T18:05:47+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-191-2026</id>
            <title type="html">Bone transport in the management of fracture-related infection: current concepts and innovations
            </title>
            <link href="https://doi.org/10.5194/jbji-11-191-2026"/>
            <summary type="html">
                &lt;b&gt;Bone transport in the management of fracture-related infection: current concepts and innovations&lt;/b&gt;&lt;br&gt;
                Willem-Jan Metsemakers, Austin T. Fragomen, Mario Morgenstern, Steffen B. Rosslenbroich, Stephen M. Quinnan, Pablo S. Corona, Mitchell Bernstein, and Kevin Tetsworth&lt;br&gt;
                    J. Bone Joint Infect., 11, 191&#8211;206, https://doi.org/10.5194/jbji-11-191-2026, 2026&lt;br&gt;
                Segmental bone loss remains a major challenge, often worsened by fracture-related infection (FRI). Surgical debridement and tissue cultures are key initial steps. Bone transport, utilizing distraction osteogenesis, remains a key therapeutic strategy. Innovations like integrated fixation and motorized nails reduce patient morbidity. Management relies on a multidisciplinary approach. This review explores current and emerging concepts in the field of bone transport, focusing on FRI.
            </summary>
            <content type="html">
                &lt;b&gt;Bone transport in the management of fracture-related infection: current concepts and innovations&lt;/b&gt;&lt;br&gt;
                Willem-Jan Metsemakers, Austin T. Fragomen, Mario Morgenstern, Steffen B. Rosslenbroich, Stephen M. Quinnan, Pablo S. Corona, Mitchell Bernstein, and Kevin Tetsworth&lt;br&gt;
                    J. Bone Joint Infect., 11, 191&#8211;206, https://doi.org/10.5194/jbji-11-191-2026, 2026&lt;br&gt;
                <p>Despite advances in musculoskeletal trauma care, segmental bone loss remains a major clinical challenge. A substantial proportion of these cases are associated with fracture-related infection (FRI), which fundamentally alters the biological environment and reconstructive strategy. In this context, FRI should be considered in any patient with a segmental bone defect, and thorough surgical debridement with acquisition of multiple deep-tissue cultures represents an essential first step in management. The presence of infection reduces the likelihood of bone consolidation and eradication of disease, emphasizing the need for strict adherence to established FRI treatment principles. Depending on the extent of bone loss, host factors, and available expertise, patients may be eligible for a range of reconstructive options. Bone transport is one of these surgical methods and involves the gradual translocation of bone segments to reconstruct defects in long bones. Based on the principles of distraction osteogenesis (DO), controlled mechanical distraction promotes predictable bone regeneration according to Ilizarov's principles. Traditionally, DO has relied on circular external fixators. Recent developments involving integrated fixation, such as bone transport over a nail, have reduced morbidity and enabled faster reconstruction. Although these techniques carry a risk of contaminating the intramedullary canal, exclusive long-term use of external fixators is not harmless. Further innovations, such as motorized telescopic intramedullary nails, have led to the gradual replacement of external fixation, making the procedure less burdensome for patients. Advances in surgical skills and technology have enabled the treatment of more complex cases, making a specialized, multidisciplinary approach essential in modern clinical care.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-04-01T18:05:47+02:00</published>
            <updated>2026-04-01T18:05:47+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-185-2026</id>
            <title type="html">A hidden threat: a case of relapsed  disseminated <i>Mycobacterium abscessus</i>  infection and its therapeutic challenges
            </title>
            <link href="https://doi.org/10.5194/jbji-11-185-2026"/>
            <summary type="html">
                &lt;b&gt;A hidden threat: a case of relapsed  disseminated Mycobacterium abscessus  infection and its therapeutic challenges&lt;/b&gt;&lt;br&gt;
                Katherine Grace Egan, Lisa Duffy, Catherine Fleming, Padraig McGettrick, Eavan G. Muldoon, Christine Kelly, James Woo, Emer Kilbride, Joseph Butler, Richard Storey, Christine Quinlan, Edward McDermott, Jonathan Hunter, and Carlos Mejia-Chew&lt;br&gt;
                    J. Bone Joint Infect., 11, 185&#8211;189, https://doi.org/10.5194/jbji-11-185-2026, 2026&lt;br&gt;
                Disseminated <em>Mycobacterium abscessus</em&gt; infection is a rare clinical presentation that is challenging to treat due to the limited number of therapeutic options available. This complex case involved multi-speciality input across two hospitals. In the absence of guidelines for the management of extra-pulmonary and disseminated disease, our case &amp;#160;highlights which pharmacological agents were used and how surgery was utilised to achieve source control.
            </summary>
            <content type="html">
                &lt;b&gt;A hidden threat: a case of relapsed  disseminated Mycobacterium abscessus  infection and its therapeutic challenges&lt;/b&gt;&lt;br&gt;
                Katherine Grace Egan, Lisa Duffy, Catherine Fleming, Padraig McGettrick, Eavan G. Muldoon, Christine Kelly, James Woo, Emer Kilbride, Joseph Butler, Richard Storey, Christine Quinlan, Edward McDermott, Jonathan Hunter, and Carlos Mejia-Chew&lt;br&gt;
                    J. Bone Joint Infect., 11, 185&#8211;189, https://doi.org/10.5194/jbji-11-185-2026, 2026&lt;br&gt;
                <p><i>Mycobacterium abscessus</i&gt; (<i>M.&amp;#160;abscessus</i>) is a rapidly growing nontuberculous mycobacterium&amp;#160;(NTM). We present the case of a 57-year-old female on immunosuppressive therapy for polymyalgia rheumatica&amp;#160;(PMR) who developed disseminated <i>M.&amp;#160;abscessus</i&gt; infection with vertebral osteomyelitis following bariatric surgery abroad. Her case highlights core treatment principles of disseminated NTM infections.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-03-30T18:05:47+02:00</published>
            <updated>2026-03-30T18:05:47+02:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-175-2026</id>
            <title type="html">Diagnostic parameters in native joint septic arthritis  and development of a new evaluation score
            </title>
            <link href="https://doi.org/10.5194/jbji-11-175-2026"/>
            <summary type="html">
                &lt;b&gt;Diagnostic parameters in native joint septic arthritis  and development of a new evaluation score&lt;/b&gt;&lt;br&gt;
                Lorenz Huber, Hasan S. Aguicenoglu, Susanne Baertl, Julia Elisabeth Lenz, Kristina Gerhardinger, Frank Hanses, Florian Zeman, Nike Walter, Volker Alt, and Markus Rupp&lt;br&gt;
                    J. Bone Joint Infect., 11, 175&#8211;183, https://doi.org/10.5194/jbji-11-175-2026, 2026&lt;br&gt;
                Septic arthritis is a dangerous joint infection that requires rapid treatment. We analysed patient data to test common blood and synovial fluid markers and a newly developed composite score combining these markers. The score demonstrated higher sensitivity than individual tests alone within this dataset. Prospective validation in larger cohorts is required before clinical application.
            </summary>
            <content type="html">
                &lt;b&gt;Diagnostic parameters in native joint septic arthritis  and development of a new evaluation score&lt;/b&gt;&lt;br&gt;
                Lorenz Huber, Hasan S. Aguicenoglu, Susanne Baertl, Julia Elisabeth Lenz, Kristina Gerhardinger, Frank Hanses, Florian Zeman, Nike Walter, Volker Alt, and Markus Rupp&lt;br&gt;
                    J. Bone Joint Infect., 11, 175&#8211;183, https://doi.org/10.5194/jbji-11-175-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: Septic arthritis&amp;#160;(SA) is an orthopaedic emergency; delayed treatment endangers joint function and survival. Unlike periprosthetic infections, diagnostic criteria for native joints are poorly standardized. This study aimed to (1)&amp;#160;evaluate diagnostic parameters including synovial white blood cell&amp;#160;(sWBC) count, neutrophil percentage, serum C-reactive protein&amp;#160;(CRP), and leukocyte count and (2)&amp;#160;assess a new evaluation score combining these parameters. <strong>Methods</strong>: In a retrospective cohort study, cases of knee and shoulder SA&amp;#160;treated at a German university hospital (2013&amp;#8211;2022) were analysed. Parameters included synovial fluid analysis&amp;#160;(sWBC, neutrophils), blood samples&amp;#160;(CRP, leukocytes), and intraoperative cultures. Cut-offs for sWBC and neutrophils were determined using receiver-operating characteristic (ROC) analysis and the Youden index, comparing SA&amp;#160;patients with non-infected controls. A new evaluation score for&amp;#160;SA (Septic Arthritis Evaluation Score, SAES) was created: 2&amp;#160;points each for sWBC and neutrophils and 1&amp;#160;point each for CRP and leukocytes. <strong>Results</strong>: Complete data were available for 45&amp;#160;patients (71.4&amp;#8201;% male, mean age 64.3&amp;#160;years). Knees were affected in 73.7&amp;#8201;%, and shoulders were affected in 26.3&amp;#8201;%. Median values were as follows: leukocytes &amp;#8211; 11/nl, CRP &amp;#8211; 158&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, sWBC &amp;#8211; 42&amp;#8201;910/<span class="inline-formula">&amp;#181;</span>L, and neutrophils &amp;#8211; 93.6&amp;#8201;%. ROC analysis identified an optimal sWBC cut-off of 35&amp;#8201;650/<span class="inline-formula">&amp;#181;</span>L (sensitivity of 64.4&amp;#8201;%, specificity of 87.8&amp;#8201;%). The SAES showed higher discriminatory performance; with a threshold&amp;#8201;<span class="inline-formula">&amp;#8805;</span>&amp;#8201;3&amp;#160;points, sensitivity was 95.6&amp;#8201;%, and specificity was 70.7&amp;#8201;%. <strong>Conclusions</strong>: In this retrospective cohort, commonly used laboratory parameters for native joint SA&amp;#160;showed limited discriminatory ability when applied individually. A newly developed composite score combining synovial and serum markers demonstrated higher sensitivity within this dataset. Prospective validation in larger cohorts is required before clinical application.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-03-23T18:05:47+01:00</published>
            <updated>2026-03-23T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-161-2026</id>
            <title type="html">Combined analysis of host immune response, biofilm genes, and 16S rRNA detection in fracture-related infection: an observational cohort study
            </title>
            <link href="https://doi.org/10.5194/jbji-11-161-2026"/>
            <summary type="html">
                &lt;b&gt;Combined analysis of host immune response, biofilm genes, and 16S rRNA detection in fracture-related infection: an observational cohort study&lt;/b&gt;&lt;br&gt;
                Melissa Depypere, Jonathan Sliepen, Jolien Onsea, Yves Debaveye, T. Fintan Moriarty, Elena Della Bella, Emmanuel André, Johan Van Weyenbergh, and Willem-Jan Metsemakers&lt;br&gt;
                    J. Bone Joint Infect., 11, 161&#8211;173, https://doi.org/10.5194/jbji-11-161-2026, 2026&lt;br&gt;
                The aim of this proof-of-concept study was to investigate host immune gene expression through transcriptome profiling in patients with fracture-related infection and to explore the feasibility of detecting 16S rRNA and biofilm-associated genes, an approach not previously applied using this method. This technique revealed distinct immune activation patterns in fracture-related infection (FRI) and enabled the identification of pathogens that were missed by conventional culture techniques.&amp;#160;
            </summary>
            <content type="html">
                &lt;b&gt;Combined analysis of host immune response, biofilm genes, and 16S rRNA detection in fracture-related infection: an observational cohort study&lt;/b&gt;&lt;br&gt;
                Melissa Depypere, Jonathan Sliepen, Jolien Onsea, Yves Debaveye, T. Fintan Moriarty, Elena Della Bella, Emmanuel André, Johan Van Weyenbergh, and Willem-Jan Metsemakers&lt;br&gt;
                    J. Bone Joint Infect., 11, 161&#8211;173, https://doi.org/10.5194/jbji-11-161-2026, 2026&lt;br&gt;
                <p>Fracture-related infection (FRI) is a serious complication in orthopaedic trauma that can lead to delayed union, nonunion, and poor clinical outcomes. A better understanding of the host immune response may provide valuable insights into the pathophysiology of FRI and may help identify genomic elements that contribute to the infection. This observational study compared immune responses between patients with FRI and non-infected controls using bone/tissue biopsies and sonication fluid, and it explored the possibility of detecting bacterial and biofilm genes using transcriptome profiling with hybridization technology (nCounter<sup>&amp;#174;</sup&gt; RNA hybridization technology). A total of 15 infected patients demonstrated significant upregulation of the innate immune pathway, including Toll-like receptor (TLR) signalling and the MyD88 cascade, suggesting an active immune response contributing to both infection control and bone resorption. Among the differentially expressed genes, PTGS2 (COX-2) showed the highest level of upregulation in the infection group. Bone biopsies showed enhanced chemokine (e.g. <i>CXCL1, CXCL2, CCL4/L1/L2</i>) signalling, with higher levels compared to tissue biopsies. Transcriptomic analysis identified bacterial transcripts in cases where conventional culture was negative, revealing potential cases of low-bacterial-load infections causing culture-negativity. Transcriptome profiling exposed distinct immune activation patterns in FRI and enabled the detection of pathogens missed by conventional culture. These findings call for larger, prospective studies to further explore the clinical utility of transcriptomics in understanding and managing FRI.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-03-12T18:05:47+01:00</published>
            <updated>2026-03-12T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-149-2026</id>
            <title type="html">Advancing diagnostics in suspected periprosthetic joint infections using synthetic synovial fluid and microcalorimetry
            </title>
            <link href="https://doi.org/10.5194/jbji-11-149-2026"/>
            <summary type="html">
                &lt;b&gt;Advancing diagnostics in suspected periprosthetic joint infections using synthetic synovial fluid and microcalorimetry&lt;/b&gt;&lt;br&gt;
                Amber De Bleeckere, Jeroen Neyt, Jasper Van Heuverswyn, Stien Vandendriessche, Hannelore Hamerlinck, Annelynn Wallaert, Christophe Pattyn, Bruno Verhasselt, Jerina Boelens, and Tom Coenye&lt;br&gt;
                    J. Bone Joint Infect., 11, 149&#8211;160, https://doi.org/10.5194/jbji-11-149-2026, 2026&lt;br&gt;
                Timely and accurate pathogen identification is essential for managing periprosthetic joint infections (PJIs), yet conventional culturing often yields false negatives and requires prolonged incubation. We evaluated an in-vivo-like synovial fluid medium and isothermal microcalorimetry. The combined use of these approaches improved detection rates and reduced time to diagnosis, offering valuable insights to advance PJI diagnostics and support better clinical decision-making.
            </summary>
            <content type="html">
                &lt;b&gt;Advancing diagnostics in suspected periprosthetic joint infections using synthetic synovial fluid and microcalorimetry&lt;/b&gt;&lt;br&gt;
                Amber De Bleeckere, Jeroen Neyt, Jasper Van Heuverswyn, Stien Vandendriessche, Hannelore Hamerlinck, Annelynn Wallaert, Christophe Pattyn, Bruno Verhasselt, Jerina Boelens, and Tom Coenye&lt;br&gt;
                    J. Bone Joint Infect., 11, 149&#8211;160, https://doi.org/10.5194/jbji-11-149-2026, 2026&lt;br&gt;
                <p>Rapid and accurate pathogen detection is essential for effective management of periprosthetic joint infections (PJIs), yet conventional culturing (CC) often yields false-negative results and requires prolonged incubation times. In the present study we compared the performance of CC to that of two alternative approaches, i.e., culturing in synthetic synovial fluid (SSF2) and isothermal microcalorimetry (IMC).</p&gt;        <p>A total of 79 synovial fluid (SF) samples from patients with suspected PJI were included; for these samples, CC data were available. Samples were incubated in SSF2 (aerobically and anaerobically, for 10&amp;#8201;d), and isolates were identified by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS). With IMC we determined the time to detect microbial activity in the samples (in two different media; brain heart infusion (BHI) broth and fluid thioglycolate medium (FTM)).</p&gt;        <p>Culturing in SSF2 yielded the highest positivity rate (53.2&amp;#8201;%), followed by IMC and CC (34.2&amp;#8201;% and 32.9&amp;#8201;%, respectively). More than one-third of all positive samples were detected only after culturing in SSF2 (39.3&amp;#8201;%), and this approach also revealed the greatest microbial diversity. IMC enabled rapid detection of microbial activity in a sample, with median detection times of 15.9&amp;#8201;h in BHI and 15.6&amp;#8201;h in FTM.</p&gt;        <p>Our results demonstrate that culturing of SF samples in SSF2 increased the diagnostic yield and that IMC reduced the time to identify clinical samples that contain viable microorganisms. This highlights the potential of these approaches; however further optimization is warranted to integrate them in diagnostic PJI workflows.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-03-11T18:05:47+01:00</published>
            <updated>2026-03-11T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-139-2026</id>
            <title type="html">Malnutrition affects infection rates and quality of life in patients undergoing primary hip and knee arthroplasty:  a retrospective study
            </title>
            <link href="https://doi.org/10.5194/jbji-11-139-2026"/>
            <summary type="html">
                &lt;b&gt;Malnutrition affects infection rates and quality of life in patients undergoing primary hip and knee arthroplasty:  a retrospective study&lt;/b&gt;&lt;br&gt;
                Domenico De Mauro, Chiara Comisi, Valeria Maccauro, Giovanni Balato, Sebastian Meller, Martina Di Martino, Fabiana Arduini, Giulio Maccauro, and Raffaele Vitiello&lt;br&gt;
                    J. Bone Joint Infect., 11, 139&#8211;147, https://doi.org/10.5194/jbji-11-139-2026, 2026&lt;br&gt;
                This retrospective study analyzed 682 patients who underwent primary total hip or knee arthroplasty to evaluate the impact of malnutrition on post-operative outcomes. Malnutrition, as defined by the Nutritional Risk Screening 2002 (NRS-2002) and controlling nutritional status (CONUT) scores, was significantly associated with higher rates of post-operative infection and poorer quality-of-life scores. Early nutritional assessment may improve post-operative recovery and reduce complication rates.
            </summary>
            <content type="html">
                &lt;b&gt;Malnutrition affects infection rates and quality of life in patients undergoing primary hip and knee arthroplasty:  a retrospective study&lt;/b&gt;&lt;br&gt;
                Domenico De Mauro, Chiara Comisi, Valeria Maccauro, Giovanni Balato, Sebastian Meller, Martina Di Martino, Fabiana Arduini, Giulio Maccauro, and Raffaele Vitiello&lt;br&gt;
                    J. Bone Joint Infect., 11, 139&#8211;147, https://doi.org/10.5194/jbji-11-139-2026, 2026&lt;br&gt;
                <p><strong>Background</strong>: Although malnutrition is globally associated with incremental morbidity, mortality, and cost, there has been a fundamental lack of consensus on diagnostic criteria for application in clinical settings. The study aims were (i)&amp;#160;to identify the role of malnutrition as an independent risk factor for complications in the total joint arthroplasty (TJA) context; and (ii)&amp;#160;to analyse the impact of malnutrition on treatment success, specifically in terms of patient-reported quality of life. <strong>Methods</strong>: The study retrospectively analysed 1070 patients undergoing total hip or knee arthroplasty between January 2019 and July 2022. Before the surgery, patients' nutritional status were assessed through Nutritional Risk Screening 2002 (NRS-2002) and controlling nutritional status (CONUT) scores. Patients were classified in two different groups: patients with NRS&amp;#8201;<span class="inline-formula">&amp;#8805;</span>&amp;#8201;3 were included in the Malnutrition group, and patients with NRS&amp;#8201;<span class="inline-formula"><</span>&amp;#8201;3 in the Control group. <strong>Results</strong>: A total number of 682 patients was included in the study. Mean age was 70.1&amp;#8201;<span class="inline-formula">&amp;#177;</span>&amp;#8201;9.6, 53&amp;#8201;% women ratio, BMI 28.1&amp;#8201;<span class="inline-formula">&amp;#177;</span>&amp;#8201;4.8&amp;#8201;kg&amp;#8201;m<span class="inline-formula"><sup>&amp;#8722;2</sup></span>. A univariate regression, adjusted for age and sex, was performed. Both NRS-2002 and the CONUT score were significant risk factors in infectious complications and in EQ5 domains of quality-of-life assessment (<span class="inline-formula"><i>p</i><0.05</span>). <strong>Conclusions</strong>: Malnutrition, as identified by both the NRS-2002 and CONUT scores, emerges as an independent risk factor, contributing to worse post-operative outcomes and increased complications, thereby decreasing the potential benefits of TJAs. Pre-operative nutritional assessment and targeted intervention to address malnutrition can play a crucial role in improving clinical outcomes, quality of life, and complication rates.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-03-04T18:05:47+01:00</published>
            <updated>2026-03-04T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-123-2026</id>
            <title type="html">Septic arthritis and prosthetic joint infections: microbial spectrum and evolving resistance patterns
            </title>
            <link href="https://doi.org/10.5194/jbji-11-123-2026"/>
            <summary type="html">
                &lt;b&gt;Septic arthritis and prosthetic joint infections: microbial spectrum and evolving resistance patterns&lt;/b&gt;&lt;br&gt;
                Merve Gürler, Füsun Kırca, and Bedia Dinç&lt;br&gt;
                    J. Bone Joint Infect., 11, 123&#8211;137, https://doi.org/10.5194/jbji-11-123-2026, 2026&lt;br&gt;
                This study examined thousands of joint fluid samples to understand which bacteria cause infections in natural and artificial joints. Staphylococci were the main culprits, and antibiotic resistance increased over time, especially in methicillin-resistant and beta-lactamase-producing strains. Testing joint fluids in blood culture bottles improved detection, helping doctors to choose more effective treatments and protect joint health.
            </summary>
            <content type="html">
                &lt;b&gt;Septic arthritis and prosthetic joint infections: microbial spectrum and evolving resistance patterns&lt;/b&gt;&lt;br&gt;
                Merve Gürler, Füsun Kırca, and Bedia Dinç&lt;br&gt;
                    J. Bone Joint Infect., 11, 123&#8211;137, https://doi.org/10.5194/jbji-11-123-2026, 2026&lt;br&gt;
                <p><strong>Background</strong>: Septic arthritis&amp;#160;(SA) and prosthetic joint infection&amp;#160;(PJI) are severe musculoskeletal emergencies associated with rapid joint destruction, functional disability, and high mortality. Accurate microbiological diagnosis remains challenging, particularly in PJIs where biofilm formation reduces culture sensitivity. Local epidemiological data are essential to optimize empirical therapy and stewardship strategies. This study aimed to determine the distribution of microorganisms isolated from synovial fluid cultures and to evaluate antimicrobial resistance trends, with a direct comparison between native&amp;#160;SA and PJI over a 5-year period. <strong>Methods</strong>: We retrospectively analyzed 3171&amp;#160;synovial fluid specimens collected between January&amp;#160;2020 and December&amp;#160;2024 at a tertiary referral hospital. Microorganisms were identified by MALDI-TOF&amp;#160;MS, and antimicrobial susceptibility was tested with VITEK-2 according to EUCAST criteria. Resistance trends were assessed for major pathogens. <strong>Results</strong>: Overall, 651&amp;#160;samples (20.5&amp;#8201;%) yielded growth, with significantly higher positivity in blood culture bottles than sterile containers (29.6&amp;#8201;% vs.&amp;#160;16.1&amp;#8201;%, <span class="inline-formula"><i>p</i><0.001</span>). PJIs accounted for 47.8&amp;#8201;% of positive cultures. The most frequent pathogens were <i>Staphylococcus aureus</i&gt; (33.6&amp;#8201;%), coagulase-negative staphylococci&amp;#160;(CoNS) (24.9&amp;#8201;%), and <i>Pseudomonas aeruginosa</i&gt; (8.6&amp;#8201;%). CoNS (<span class="inline-formula"><i>p</i>=0.017</span>) and <i>E.&amp;#160;faecalis</i&gt; (<span class="inline-formula"><i>p</i>=0.009</span>) were significantly more common in PJIs. Methicillin resistance increased among <i>S.&amp;#160;aureus</i&gt; (20.0&amp;#8201;%&amp;#8201;<span class="inline-formula">&amp;#8594;</span>&amp;#8201;30.8&amp;#8201;%) and remained high among CoNS (51&amp;#8201;%&amp;#8211;85&amp;#8201;%). Extended-spectrum <span class="inline-formula"><i>&amp;#946;</i></span>-lactamase&amp;#160;(ESBL) prevalence rose in <i>K.&amp;#160;pneumoniae</i&gt; (14.3&amp;#8201;%&amp;#8201;<span class="inline-formula">&amp;#8594;</span>&amp;#8201;42.1&amp;#8201;%) and remained high in <i>E.&amp;#160;coli</i&gt; (57&amp;#8201;%&amp;#8211;80&amp;#8201;%). All staphylococcal isolates remained susceptible to glycopeptides, linezolid, and daptomycin. <strong>Conclusions</strong>: Staphylococci remain the dominant pathogens in joint infections, with CoNS and <i>E.&amp;#160;faecalis</i&gt; strongly associated with PJIs. Rising methicillin resistance and ESBL-producing Enterobacterales highlight the need for careful empirical coverage, while preserved activity of last-line agents is reassuring. Routine inoculation into blood culture bottles significantly improves diagnostic yield.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-02-25T18:05:47+01:00</published>
            <updated>2026-02-25T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-113-2026</id>
            <title type="html">Treatment of periprosthetic joint infection &#8211;  outcomes following algorithm-guided treatment at a multidisciplinary referral centre
            </title>
            <link href="https://doi.org/10.5194/jbji-11-113-2026"/>
            <summary type="html">
                &lt;b&gt;Treatment of periprosthetic joint infection –  outcomes following algorithm-guided treatment at a multidisciplinary referral centre&lt;/b&gt;&lt;br&gt;
                Christian Merz, Jan Klaas, Rik Osinga, Parham Sendi, Richard Alexander Kuehl, Mario Morgenstern, and Martin Clauss&lt;br&gt;
                    J. Bone Joint Infect., 11, 113&#8211;121, https://doi.org/10.5194/jbji-11-113-2026, 2026&lt;br&gt;
                Founded in 2019, the Center for Musculoskeletal Infections at University Hospital Basel was established to implement standardized, multidisciplinary care for orthopaedic and trauma-related infections. This retrospective analysis of hip and knee periprosthetic joint infections (2019&amp;#8211;2022) illustrates the feasibility and effectiveness of this structured approach, with infection control achieved in the majority of patients despite case complexity.
            </summary>
            <content type="html">
                &lt;b&gt;Treatment of periprosthetic joint infection –  outcomes following algorithm-guided treatment at a multidisciplinary referral centre&lt;/b&gt;&lt;br&gt;
                Christian Merz, Jan Klaas, Rik Osinga, Parham Sendi, Richard Alexander Kuehl, Mario Morgenstern, and Martin Clauss&lt;br&gt;
                    J. Bone Joint Infect., 11, 113&#8211;121, https://doi.org/10.5194/jbji-11-113-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: This study evaluated early treatment outcomes and the management of complications in patients with periprosthetic joint infection (PJI) of the hip and knee treated at a specialized centre using an algorithm-guided multidisciplinary team (MDT) approach. <strong>Methods</strong>: This prospective cohort includes all consecutive patients treated for acute or chronic PJI between December 2019 and December 2022, with a minimum 1-year follow-up. PJI was defined according to the criteria of the European Bone and Joint Infection Society (EBJIS). Surgical decisions were based on a published treatment algorithm. The primary outcome was treatment success at 1 year after the last PJI surgery. <strong>Results</strong>: 106 patients were included according to prespecified criteria, with a median age of 74 years (IQR 66&amp;#8211;82) and follow-up of 24 months (IQR 15&amp;#8211;28). 79 patients (75&amp;#8201;%) were referred from other institutions. 44 patients (42&amp;#8201;%) were treated with debridement, antibiotics, and implant retention (DAIR); 17 (16&amp;#8201;%) were treated with one-stage revision; and 45 (42&amp;#8201;%) were treated with two-stage revision. 9 patients (8&amp;#8201;%) needed plastic surgery for soft tissue reconstruction. The 1-year infection-free survival (Delphi-based consensus criteria) was 69&amp;#8201;% (95&amp;#8201;% CI: 60&amp;#8201;%&amp;#8211;78&amp;#8201;%). Within 1 year, 14 (13.2&amp;#8201;%) septic and 12 (11.3&amp;#8201;%) aseptic failures occurred after a median of 0.5 months (IQR 0.4&amp;#8211;1) and were successfully treated in most patients. 12 patients (11&amp;#8201;%) died after a median of 0.8 months (IQR 0.3&amp;#8211;2.8). <strong>Conclusion</strong>: Our results demonstrate the value of an algorithm-driven MDT approach as an effective strategy for managing complex PJI patients and PJI-surgery-related complications in a specialized referral centre for bone and joint infections.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-02-12T18:05:47+01:00</published>
            <updated>2026-02-12T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-83-2026</id>
            <title type="html">High failure rate in <i>Pseudomonas aeruginosa</i>-associated periprosthetic hip and knee joint infections
            </title>
            <link href="https://doi.org/10.5194/jbji-11-83-2026"/>
            <summary type="html">
                &lt;b&gt;High failure rate in Pseudomonas aeruginosa-associated periprosthetic hip and knee joint infections&lt;/b&gt;&lt;br&gt;
                Ece Akcicek, Jennyfer A. Mitterer, Veronika Achatz, Tamino Szirmay, Sujeesh Sebastian, and Jochen G. Hofstaetter&lt;br&gt;
                    J. Bone Joint Infect., 11, 83&#8211;94, https://doi.org/10.5194/jbji-11-83-2026, 2026&lt;br&gt;
                <em>Pseudomonas aeruginosa </em>is a common pathogen in Gram-negative periprosthetic joint infections (PJIs). It is resistant to many antibiotics and forms biofilm, making it difficult to treat. We analyzed 1286 patients who underwent 1640 surgeries; among them, 38 patients with 50 procedures had <em>P. aeruginosa</em>. Most infections were chronic, often in hip revisions, with a high failure rate and recurrence. Due to its clinical and microbiological features, <em>P. aeruginosa</em>-related PJIs remain challenging.</p>
<div id="accel-snackbar"></div>
            </summary>
            <content type="html">
                &lt;b&gt;High failure rate in Pseudomonas aeruginosa-associated periprosthetic hip and knee joint infections&lt;/b&gt;&lt;br&gt;
                Ece Akcicek, Jennyfer A. Mitterer, Veronika Achatz, Tamino Szirmay, Sujeesh Sebastian, and Jochen G. Hofstaetter&lt;br&gt;
                    J. Bone Joint Infect., 11, 83&#8211;94, https://doi.org/10.5194/jbji-11-83-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: <i>Pseudomonas aeruginosa</i&gt; is one of the most common Gram-negative&amp;#160;(GN) pathogens in periprosthetic joint infections&amp;#160;(PJIs). However, not many data are available on them. This study aimed to evaluate the prevalence of <i>P.&amp;#160;aeruginosa</i&gt; in hip and knee PJIs, patient characteristics, types of infection, resistance patterns, treatments, and outcomes. <strong>Methods</strong>: We retrospectively analyzed culture-positive revision total hip and knee arthroplasties&amp;#160;(rTHA and rTKA) from&amp;#160;2008 to&amp;#160;2023. Cases were evaluated according to the International Consensus Meeting (ICM) 2018 and European Bone and Joint Infection Society (EBJIS) criteria&amp;#160;2021. The success rate was calculated according to Tier classification. <strong>Results</strong>: Among 1640&amp;#160;revision procedures performed on 1286&amp;#160;patients, 195&amp;#160;revisions in 160&amp;#160;patients were positive for GN microorganisms, including 50&amp;#160;<i>P.&amp;#160;aeruginosa</i&gt; cases (3.1&amp;#8201;%, hip/knee:&amp;#160;39/11) in 38&amp;#160;patients. Most were chronic (64&amp;#8201;%), monomicrobial (74&amp;#8201;%) infections, particularly infected rTHA (63.8&amp;#8201;%). <i>Proteus mirabilis</i&gt; was the main co-pathogen (23.1&amp;#8201;%) in polymicrobial infections. The mean follow-up time was 65.4&amp;#160;months. The most frequent surgical intervention was two-stage exchange (48&amp;#8201;%). Chronic infections required significantly more total revisions than acute cases. Success rates decreased with each additional revision. Antibiotic resistance developed in three patients during subsequent revisions. The overall success rate was 46&amp;#8201;%. Reinfection-free survival decreased from 95&amp;#8201;% at 12&amp;#160;months to 22.4&amp;#8201;% after 10 years. <strong>Conclusion</strong>: In our patient cohort, <i>Pseudomonas aeruginosa</i&gt; accounted for one-third of hip and knee GN PJIs, was mostly found in infected rTHA, and was monomicrobial. Changes in antimicrobial resistance, high failure rates, and low long-term infection-free survival underline that <i>Pseudomonas aeruginosa</i&gt; is a challenging PJI pathogen.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-02-10T18:05:47+01:00</published>
            <updated>2026-02-10T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-95-2026</id>
            <title type="html">Safety of locally applied antibiotics in orthopaedic  trauma surgery: descriptive results from  a prospective cohort study
            </title>
            <link href="https://doi.org/10.5194/jbji-11-95-2026"/>
            <summary type="html">
                &lt;b&gt;Safety of locally applied antibiotics in orthopaedic  trauma surgery: descriptive results from  a prospective cohort study&lt;/b&gt;&lt;br&gt;
                Niels Vanvelk, Esther M. M. Van Lieshout, Leendert H. T. Nugteren, A. Cornelis Plaisier, Rosalya Van der Pot, Corine Bethlehem, Willem-Jan Metsemakers, William T. Obremskey, and Michael H. J. Verhofstad&lt;br&gt;
                    J. Bone Joint Infect., 11, 95&#8211;103, https://doi.org/10.5194/jbji-11-95-2026, 2026&lt;br&gt;
                Although local antibiotic administration is used to prevent and treat fracture-related infections, concerns remain about systemic absorption and potential renal toxicity. This study assessed serum levels and renal function after local gentamicin or vancomycin use. Gentamicin exceeded the lower limit of quantification in 17% of cases but remained below toxic levels. Vancomycin was undetectable. These findings suggest that local antibiotic administration does not harm renal function.
            </summary>
            <content type="html">
                &lt;b&gt;Safety of locally applied antibiotics in orthopaedic  trauma surgery: descriptive results from  a prospective cohort study&lt;/b&gt;&lt;br&gt;
                Niels Vanvelk, Esther M. M. Van Lieshout, Leendert H. T. Nugteren, A. Cornelis Plaisier, Rosalya Van der Pot, Corine Bethlehem, Willem-Jan Metsemakers, William T. Obremskey, and Michael H. J. Verhofstad&lt;br&gt;
                    J. Bone Joint Infect., 11, 95&#8211;103, https://doi.org/10.5194/jbji-11-95-2026, 2026&lt;br&gt;
                <p>Antibiotic therapy holds an integral role in the prevention and treatment of fracture-related infection (FRI). Because local concentrations after systemic administration are limited by the potential for side effects, the local application of antibiotics serves as a valuable adjunct. One concern with the local administration of high amounts of aminoglycosides and vancomycin is the absorption into the systemic circulation, leading to detrimental effects on renal function. In this study, serum antibiotic concentration and renal function were measured in patients treated for open fractures or FRI using local antibiotics at 6, 24 and 48&amp;#8201;h postoperatively. Afterwards, laboratory analyses were continued daily until the concentration dropped beneath the lower limit of quantification (LLOQ) (0.22&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span&gt;  for gentamicin, 0.70&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span&gt; for vancomycin). Gentamicin concentration, vancomycin concentration and glomerular filtration rate were measured 272, 60 and 277 times in 52 patients after 82 surgeries, respectively. The LLOQ for gentamicin was exceeded in 14 surgeries (17&amp;#8201;%, median concentration 0.3&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>). The highest measured antibiotic level was 1.0&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, well below the generally accepted toxic trough level of 2.0&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>. Although the total quantity of antibiotics delivered via beads was less than that provided by an antibiotic spacer, the use of beads more frequently yielded measurements exceeding the established threshold. None of the vancomycin measurements surpassed the LLOQ. The results of this study suggest that the current clinical use of locally applied antibiotics in orthopaedic trauma surgery is safe in the context of nephrotoxicity. The type of antibiotic carrier might affect local release and subsequent systemic absorption, which must be considered.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-02-10T18:05:47+01:00</published>
            <updated>2026-02-10T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-105-2026</id>
            <title type="html">How much are we willing to do for the ones we love &#8211;   impact on caregivers of patients suffering from periprosthetic joint infections: a qualitative study
            </title>
            <link href="https://doi.org/10.5194/jbji-11-105-2026"/>
            <summary type="html">
                &lt;b&gt;How much are we willing to do for the ones we love –   impact on caregivers of patients suffering from periprosthetic joint infections: a qualitative study&lt;/b&gt;&lt;br&gt;
                Franz-Joseph Dally, Franziska Prüßner, Frederic Bludau, Sascha Gravius, Ali Darwich, and Marcel Betsch&lt;br&gt;
                    J. Bone Joint Infect., 11, 105&#8211;112, https://doi.org/10.5194/jbji-11-105-2026, 2026&lt;br&gt;
                Periprosthetic joint infection (PJI) patient care has both positive and negative impacts on caregivers: (1) conflicts regarding the hospital stay, (2) novel personal challenges, (3) nursing, (4) emotional and psychological consequences, and (5) effects on the relationship. To conclude, caregivers of PJI patients shoulder a relevant burden both physically and emotionally, which seems to be very similar to caregivers of cancer patients. An inclusion in established treatment algorithms for PJI should be considered.
            </summary>
            <content type="html">
                &lt;b&gt;How much are we willing to do for the ones we love –   impact on caregivers of patients suffering from periprosthetic joint infections: a qualitative study&lt;/b&gt;&lt;br&gt;
                Franz-Joseph Dally, Franziska Prüßner, Frederic Bludau, Sascha Gravius, Ali Darwich, and Marcel Betsch&lt;br&gt;
                    J. Bone Joint Infect., 11, 105&#8211;112, https://doi.org/10.5194/jbji-11-105-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: We aimed to identify and explore the psychological and physical strains that caregivers of patients suffering from a periprosthetic joint infection&amp;#160;(PJI) experience. <strong>Methods</strong>: Twenty-four qualitative semi-structured interviews with people giving care to patients suffering from a PJI were conducted by a single trained interviewer. The interviews were used to identify physical and emotional challenges that caregivers were confronted with. <strong>Results</strong>: The psychological and physical strains caregivers reported were wide-ranging and included suffering from stress and anxieties, and feelings of hopelessness and helplessness while having to function all the time to the point where, subjectively, caregivers felt as if they gave themselves up. Caregivers were suffering from mental and physical exhaustion as mainly family members and close ones provided the caregiving. Oftentimes an elaborate team effort approach was needed to lighten the caregiving burden. <strong>Conclusions</strong>: This study shows that caregivers are willing to go above and beyond for their loved ones, while exhausting and exceeding their individual resources. Caregivers of PJI patients deal with major issues. Specifically, we identified (1)&amp;#160;conflicts regarding the hospital stay, (2)&amp;#160;novel personal challenges, (3)&amp;#160;nursing, (4)&amp;#160;emotional and psychological consequences, and (5)&amp;#160;effects on the relationship. Our research shows that there is a profound need for support during and after hospitalisation, and caring for a PJI patient seems surprisingly similar to caring for a cancer patient. We recommend including the caregivers of PJI patients, and how to better support them, into the PJI treatment guidelines.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-02-10T18:05:47+01:00</published>
            <updated>2026-02-10T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-77-2026</id>
            <title type="html">Lyme in the prosthetic joint: two cases and a review of the literature
            </title>
            <link href="https://doi.org/10.5194/jbji-11-77-2026"/>
            <summary type="html">
                &lt;b&gt;Lyme in the prosthetic joint: two cases and a review of the literature&lt;/b&gt;&lt;br&gt;
                Hussam Tabaja, Matteo Passerini, Irene G. Sia, Elena Beam, and Gina A. Suh&lt;br&gt;
                    J. Bone Joint Infect., 11, 77&#8211;82, https://doi.org/10.5194/jbji-11-77-2026, 2026&lt;br&gt;
                In Lyme-endemic regions, Lyme disease should be considered in culture-negative periprosthetic joint infection (PJI). Diagnosis relies on microbial DNA detection, particularly <em>Borrelia</em>-targeted polymerase chain reaction (PCR) on synovial fluid or tissue. We present 10 cases highlighting the value of PCR for early recognition of this pathogen, which is not detectable by conventional culture media. Surgical debridement remains the standard of care, though several cases were successfully treated medically, an observation that merits further investigation.
            </summary>
            <content type="html">
                &lt;b&gt;Lyme in the prosthetic joint: two cases and a review of the literature&lt;/b&gt;&lt;br&gt;
                Hussam Tabaja, Matteo Passerini, Irene G. Sia, Elena Beam, and Gina A. Suh&lt;br&gt;
                    J. Bone Joint Infect., 11, 77&#8211;82, https://doi.org/10.5194/jbji-11-77-2026, 2026&lt;br&gt;
                <p>Lyme periprosthetic joint infection (PJI) is rare, with only 8 cases reported in the literature. In this paper, we describe 2 cases and review the prior 8 cases to better characterize its diagnosis and management. All 10 cases presented with culture-negative PJI in Lyme-endemic regions and were confirmed to have Lyme PJI via a positive <i>Borrelia</i>-targeted polymerase chain reaction (PCR) run on joint specimens. Treatment strategies varied: 5 underwent debridement, antibiotics, and implant retention (DAIR); 1 had exchange arthroplasty; and 4 were managed non-operatively. Antimicrobial treatment also varied considerably. All patients achieved clinical cure. Lyme disease should be considered a potential cause of culture-negative PJI occurring in endemic regions. Because <i>Borrelia</i>-targeted PCR is not routinely included in standard PJI diagnostic workup, diagnosis may be delayed; therefore, clinicians should consider ordering this test when Lyme PJI is part of the differential.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-02-05T18:05:47+01:00</published>
            <updated>2026-02-05T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-65-2026</id>
            <title type="html">Gentamicin fails to eradicate <i>Staphylococcus aureus</i> biofilm in vitro, even in combination with rifampin
            </title>
            <link href="https://doi.org/10.5194/jbji-11-65-2026"/>
            <summary type="html">
                &lt;b&gt;Gentamicin fails to eradicate Staphylococcus aureus biofilm in vitro, even in combination with rifampin&lt;/b&gt;&lt;br&gt;
                Willemijn Boot, Michel Schläppi, Virginia Post, T. Fintan Moriarty, and Peter Wahl&lt;br&gt;
                    J. Bone Joint Infect., 11, 65&#8211;76, https://doi.org/10.5194/jbji-11-65-2026, 2026&lt;br&gt;
                In this study, we tested whether very high doses and prolonged exposure of gentamicin, alone or with rifampin, can eliminate mature <em>Staphylococcus aureus</em&gt; biofilm &amp;#8211; one of the main causes of implant-associated infections. None of the regimes tested eradicated all bacteria. Adding rifampin gave no benefit. This suggests that aminoglycosides are not optimal for local antibiotic therapy.
            </summary>
            <content type="html">
                &lt;b&gt;Gentamicin fails to eradicate Staphylococcus aureus biofilm in vitro, even in combination with rifampin&lt;/b&gt;&lt;br&gt;
                Willemijn Boot, Michel Schläppi, Virginia Post, T. Fintan Moriarty, and Peter Wahl&lt;br&gt;
                    J. Bone Joint Infect., 11, 65&#8211;76, https://doi.org/10.5194/jbji-11-65-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: Biofilm formation is one of the key elements making orthopaedic device-related infections (ODRIs) difficult to eradicate. Aminoglycosides such as gentamicin are frequently applied via local carriers, and systemic rifampin is added for its anti-biofilm activity. However, robust in vitro evidence of their ability to eradicate mature biofilm is limited. This study assessed whether gentamicin, alone or in combination with rifampin, can eradicate established <i>Staphylococcus aureus</i&gt; biofilm in vitro. <strong>Methods</strong>: A clinical methicillin-susceptible <i>S.&amp;#160;aureus</i&gt; isolate was grown as a 5&amp;#8201;d old biofilm on a peg lid microtiter plate. Three exposure regimens were tested: (i) continuous exposure to gentamicin (15&amp;#8211;2000&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>) for 28&amp;#8201;d, (ii) intermittent 2&amp;#8201;h exposures twice daily (at 15, 250 and 2000&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>) for 28&amp;#8201;d to reflect systemic twice-daily dosing and (iii) a 14&amp;#8201;d burst release starting at 2000&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span&gt; with stepwise decline to model release from local carriers. Rifampin was either absent or added at 3.3&amp;#8201;mg&amp;#8201;L<span class="inline-formula"><sup>&amp;#8722;1</sup></span>, approximating peri-implant concentrations from preclinical pharmacokinetic studies. Biofilm viability was quantified as colony-forming units (CFUs) from sonicated pegs, and selected surviving isolates underwent susceptibility testing. <strong>Results</strong>: Across all regimens, concentration- and time-dependent decreases in CFU counts were observed, but no regimen resulted in bacterial counts falling below the lower limit of detection (LLOD). The addition of rifampin did not result in the sustained enhancement of biofilm killing, and, in some regimens, resulted in higher CFU counts. Isolates recovered from culture-positive pegs remained largely susceptible to gentamicin, whereas rifampin resistance arose sporadically. <strong>Conclusion</strong>: High-dose gentamicin exposures failed to eradicate 5&amp;#8201;d old <i>S. aureus</i&gt; biofilm in vitro, whatever the administration regimen. Rifampin co-administration did not alter the final outcome of biofilm persistence, despite its well-recognised anti-biofilm activity. These findings challenge the reliance on aminoglycoside-loaded carriers as curative strategies for ODRIs and suggest that persistent viability may reflect antibiotic tolerance that may not be overcome by antibiotics alone.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-02-02T18:05:47+01:00</published>
            <updated>2026-02-02T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-53-2026</id>
            <title type="html">Diagnosis and management of fracture-related infections in a low-income country: a prospective study comparing current practice to international consensus guidelines
            </title>
            <link href="https://doi.org/10.5194/jbji-11-53-2026"/>
            <summary type="html">
                &lt;b&gt;Diagnosis and management of fracture-related infections in a low-income country: a prospective study comparing current practice to international consensus guidelines&lt;/b&gt;&lt;br&gt;
                Loïc Fonkoué, Elizabeth K. Tissingh, Cilia Ngang, Olivier Kennedy Muluem, Jasmine Sibatcheu Simo, Richard Douvamai, Jean Bahebeck, Olivier Cornu, and Martin McNally&lt;br&gt;
                    J. Bone Joint Infect., 11, 53&#8211;63, https://doi.org/10.5194/jbji-11-53-2026, 2026&lt;br&gt;
                This study assessed whether the diagnosis and management of fracture-related infections (FRIs) in a low- and middle-income countries (LMICs) currently align with consensus guidelines. We found that two-thirds of cases are managed outside the international guidelines. While the consensus definition is applicable, diagnostic capacity remains limited and microbiological standards are often impractical. Our findings highlight the need to adapt guidelines to local realities and to strengthen capacity in LMICs.
            </summary>
            <content type="html">
                &lt;b&gt;Diagnosis and management of fracture-related infections in a low-income country: a prospective study comparing current practice to international consensus guidelines&lt;/b&gt;&lt;br&gt;
                Loïc Fonkoué, Elizabeth K. Tissingh, Cilia Ngang, Olivier Kennedy Muluem, Jasmine Sibatcheu Simo, Richard Douvamai, Jean Bahebeck, Olivier Cornu, and Martin McNally&lt;br&gt;
                    J. Bone Joint Infect., 11, 53&#8211;63, https://doi.org/10.5194/jbji-11-53-2026, 2026&lt;br&gt;
                <p>Data on the implementation of international consensus guidelines for fracture-related infection (FRI) in low- and middle-income countries (LMICs) are scarce. This study assessed whether FRI diagnosis and management in an LMIC align with these recommendations. <strong>Methods:</strong&gt; We conducted a prospective multicenter study across four tertiary hospitals in Yaound&amp;#233;, Cameroon (September 2022&amp;#8211;July 2025). All consecutive patients with a working FRI diagnosis were included. Confirmatory/suggestive diagnostic criteria and treatment strategies were assessed against consensus guidelines. <strong>Results:</strong&gt; A total of 169 patients were included (mean age 39.4&amp;#8201;<span class="inline-formula">&amp;#177;</span>&amp;#8201;15.4 years; 72.7&amp;#8201;% male). In 34.3&amp;#8201;% of cases, FRI occurred without prior surgery, limiting applicability of the Willenegger and Roth classification. Clinical confirmatory criteria were present in 97&amp;#8201;% of cases. Microbiological standards were seldom achieved: none fulfilled sampling quantity, and only 46.6&amp;#8201;% met sampling method recommendations. A microbiological confirmatory criterion was documented in 36 patients (21.3&amp;#8201;%); histopathology was rarely performed (1.2&amp;#8201;%), and nuclear imaging was not used. Most patients (81.1&amp;#8201;%) were on antibiotics before admission or surgery. The most common treatment strategies were suppressive antibiotic therapy (44.4&amp;#8201;%); one-stage (11.2&amp;#8201;%) or two-stage (10.7&amp;#8201;%) debridement, antibiotics, and implant exchange (DAIEX); and debridement, antibiotics, and implant retention (DAIR; 9.5&amp;#8201;%). Overall, 62.7&amp;#8201;% of treatments deviated from consensus guidelines. <strong>Conclusion:</strong&gt; Nearly two-thirds of FRIs in this LMIC setting were managed outside international consensus guidelines. While the consensus definition is applicable, diagnostic capacity remains limited and microbiological standards are often impractical. Context-adapted, evidence-based guidelines are urgently needed to improve outcomes where the burden is highest.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-01-29T18:05:47+01:00</published>
            <updated>2026-01-29T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-43-2026</id>
            <title type="html">Osteomyelitis in peri-implant bone of hip prosthetic joint infection: prevalence and clinical impact
            </title>
            <link href="https://doi.org/10.5194/jbji-11-43-2026"/>
            <summary type="html">
                &lt;b&gt;Osteomyelitis in peri-implant bone of hip prosthetic joint infection: prevalence and clinical impact&lt;/b&gt;&lt;br&gt;
                Ernesto Muñoz-Mahamud, Melissa Rivera, Ana Belén Larque, Laura Morata, Andrés Combalia, Alfonso Alías, Jenaro Ángel Fernández-Valencia, and Álex Soriano&lt;br&gt;
                    J. Bone Joint Infect., 11, 43&#8211;52, https://doi.org/10.5194/jbji-11-43-2026, 2026&lt;br&gt;
                Several factors have been linked to failure in chronic prosthetic joint infection revisions. We hypothesize that osteomyelitis in septic hip revisions is underestimated and may significantly impact outcomes. In this series, 30.8 % of septic revisions exhibited bone samples consistent with osteitis, mainly associated with prolonged unsuccessful surgical and antibiotic treatments, the presence of a sinus tract, and subsequent failure after implant removal.
            </summary>
            <content type="html">
                &lt;b&gt;Osteomyelitis in peri-implant bone of hip prosthetic joint infection: prevalence and clinical impact&lt;/b&gt;&lt;br&gt;
                Ernesto Muñoz-Mahamud, Melissa Rivera, Ana Belén Larque, Laura Morata, Andrés Combalia, Alfonso Alías, Jenaro Ángel Fernández-Valencia, and Álex Soriano&lt;br&gt;
                    J. Bone Joint Infect., 11, 43&#8211;52, https://doi.org/10.5194/jbji-11-43-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: Periprosthetic joint infection (PJI) after hip revision surgery shows variable failure rates, with the impact of osteomyelitis in the surrounding bone on outcomes remaining unclear. This study aims to examine bone osteomyelitis prevalence and its impact on hip PJI revision outcomes. <strong>Material and methods</strong>: This retrospective study reviewed 75 cases of chronic hip PJI patients undergoing hip revisions performed at a single center between January 2019 and June 2023. Only cases with peri-implant bone samples submitted for histology evaluation were included. Bone samples were assessed for osteomyelitis using histological criteria. Risk factors, including demographic data, preoperative infections, and previous revisions, were analyzed. Statistical significance was determined using Chi-square and Kaplan&amp;#8211;Meier survival analysis (<span class="inline-formula"><i>p</i>&amp;#8804;0.05</span>). <strong>Results</strong>: A total of 52 cases of chronic hip PJI were included for final analysis. Up to 30.8&amp;#8201;% of the cases (<span class="inline-formula"><i>n</i>=16</span>) presented histological signs of osteomyelitis. The success rate among those 36 cases where no signs of osteomyelitis were observed was 88.9&amp;#8201;%, whereas, in the 16 cases where it was present, the rate dropped to 37.5&amp;#8201;%. Histological signs of osteomyelitis were significantly associated with a prior history of multiple surgeries and unsuccessful antibiotic treatments (<span class="inline-formula"><i>p</i>=0.01</span>), the presence of a sinus tract (<span class="inline-formula"><i>p</i>=0.01</span>), and the need for additional debridement with spacer exchange after the first stage of a two-stage revision (<span class="inline-formula"><i>p</i>=0.001</span>). <strong>Conclusion</strong>: Patients with signs of osteomyelitis demonstrated a higher failure rate. Histological evaluation of periprosthetic bone should ideally be performed during the first stage of revision surgery to guide second-stage management and to improve outcomes.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-01-15T18:05:47+01:00</published>
            <updated>2026-01-15T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-31-2026</id>
            <title type="html">The proportion of chronic periprosthetic joint  infection patients with <i>Candida</i> isolates
            </title>
            <link href="https://doi.org/10.5194/jbji-11-31-2026"/>
            <summary type="html">
                &lt;b&gt;The proportion of chronic periprosthetic joint  infection patients with Candida isolates&lt;/b&gt;&lt;br&gt;
                Samuelson E. Osifo, Adrian Santana, Michael F. Shannon, Victoria R. Wong, Caroline F. Tyndall, Christian Cisneros, Niosha Parvizi, Brian A. Klatt, Johannes F. Plate, Nicolas S. Piuzzi, and Kenneth L. Urish&lt;br&gt;
                    J. Bone Joint Infect., 11, 31&#8211;41, https://doi.org/10.5194/jbji-11-31-2026, 2026&lt;br&gt;
                Fungal organisms are conventionally estimated to account for 1&amp;#8201;% &amp;#8211;2&amp;#8201;% of periprosthetic joint infection (PJI) cases, although diagnostic and reporting limitations may result in systematic underestimation. Using a quantitative missing-data sensitivity analysis across 23 studies encompassing 28&amp;#8201;253 PJI cases, we estimated an adjusted <em>Candida</em&gt; PJI proportion of approximately 5&amp;#8201;%, increasing to nearly 10&amp;#8201;% in chronic or refractory infections.
            </summary>
            <content type="html">
                &lt;b&gt;The proportion of chronic periprosthetic joint  infection patients with Candida isolates&lt;/b&gt;&lt;br&gt;
                Samuelson E. Osifo, Adrian Santana, Michael F. Shannon, Victoria R. Wong, Caroline F. Tyndall, Christian Cisneros, Niosha Parvizi, Brian A. Klatt, Johannes F. Plate, Nicolas S. Piuzzi, and Kenneth L. Urish&lt;br&gt;
                    J. Bone Joint Infect., 11, 31&#8211;41, https://doi.org/10.5194/jbji-11-31-2026, 2026&lt;br&gt;
                <p><strong>Introduction</strong>: Fungal periprosthetic joint infection&amp;#160;(PJI) has historically been reported in 1&amp;#8201;%&amp;#8211;2&amp;#8201;% of cases, with <i>Candida</i&gt; species accounting for most isolates. However, the true incidence is likely underestimated. Standard aerobic and anaerobic culture techniques have limited sensitivity for detecting fungi, single positive fungal cultures are often excluded or inconsistently classified, culture-negative infections may mask low-burden fungal pathogens, and polymicrobial cultures may obscure the contribution of fungal organisms. The objective of this study was to quantify the burden of potentially unrecognized fungal involvement and provide a more accurate estimate of the incidence of <i>Candida</i>-associated PJI. <strong>Methods</strong>: Following a systematic literature search, we performed a quantitative sensitivity analysis using imputation with informative missingness odds ratios&amp;#160;(IMORs). Reported <i>Candida</i&gt; cases were adjusted for four predefined sources of under-ascertainment: single positive cultures, negative cultures, polymicrobial cultures, and variability in fungal culture sensitivity. <strong>Results</strong>: 23 studies met inclusion criteria, reporting a total of 28&amp;#8201;253&amp;#160;PJI patients, of whom 590&amp;#160;had <i>Candida</i&gt; involvement (2.1&amp;#8201;%; range 0.9&amp;#8201;%&amp;#8211;10.1&amp;#8201;%). After imputation for missing data, the estimated proportion of PJI cases involving <i>Candida</i&gt; ranged from 1.4&amp;#8201;%&amp;#8211;13.6&amp;#8201;%, with a mean of 5.1&amp;#8201;%. The odds ratios for known risk factors for chronic refractory PJI exceeded&amp;#160;2.0, suggesting the proportion of <i>Candida</i&gt; in this population likely exceeds 10&amp;#8201;%. <strong>Conclusion</strong>: The involvement of <i>Candida</i&gt; in PJI is likely underreported. The adjusted incidence is approximately 5&amp;#8201;% across all PJI cases. Among patients with chronic refractory PJI, especially those that have failed multiple surgeries, the incidence of <i>Candida</i&gt; PJI is approximately 10&amp;#8201;%. <strong>Level of Evidence</strong>: Level&amp;#160;III.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-01-13T18:05:47+01:00</published>
            <updated>2026-01-13T18:05:47+01:00</updated>
        </entry>
        <entry>
            <id>https://doi.org/10.5194/jbji-11-15-2026</id>
            <title type="html">Synovial fluid specific gravity as an inexpensive point-of-care test for diagnosing hip and knee periprosthetic joint infection
            </title>
            <link href="https://doi.org/10.5194/jbji-11-15-2026"/>
            <summary type="html">
                &lt;b&gt;Synovial fluid specific gravity as an inexpensive point-of-care test for diagnosing hip and knee periprosthetic joint infection&lt;/b&gt;&lt;br&gt;
                Sujeesh Sebastian, Hibah A. Abusulaiman, Veronika Achatz, Matteo Spadini, Jennyfer A. Mitterer, Sebastian Simon, and Jochen G. Hofstaetter&lt;br&gt;
                    J. Bone Joint Infect., 11, 15&#8211;19, https://doi.org/10.5194/jbji-11-15-2026, 2026&lt;br&gt;
                A simple, rapid, and low-cost test measuring synovial fluid specific gravity shows high accuracy and excellent specificity for diagnosing hip and knee periprosthetic joint infection. This method can quickly help rule in infections during revision surgeries, making it a practical point-of-care tool, especially in clinics or hospitals with limited resources. Its performance supports use alongside established lab markers for better patient outcomes.
            </summary>
            <content type="html">
                &lt;b&gt;Synovial fluid specific gravity as an inexpensive point-of-care test for diagnosing hip and knee periprosthetic joint infection&lt;/b&gt;&lt;br&gt;
                Sujeesh Sebastian, Hibah A. Abusulaiman, Veronika Achatz, Matteo Spadini, Jennyfer A. Mitterer, Sebastian Simon, and Jochen G. Hofstaetter&lt;br&gt;
                    J. Bone Joint Infect., 11, 15&#8211;19, https://doi.org/10.5194/jbji-11-15-2026, 2026&lt;br&gt;
                <p>Synovial fluid specific gravity (SG) was evaluated as a rapid, inexpensive test for periprosthetic joint infection (PJI) diagnosis in revision arthroplasties. High diagnostic accuracy (area under the curve 0.89; threshold 1.007) with high specificity (100&amp;#8201;%) and moderate sensitivity (65&amp;#8201;%) was found, supporting its use as an adjunctive point-of-care (POC) tool for PJI.</p>
            </content>
            <author>
                <name>Copernicus Electronic Production Support Office</name>
            </author>
            <published>2026-01-12T18:05:47+01:00</published>
            <updated>2026-01-12T18:05:47+01:00</updated>
        </entry>
</feed>